DCIS neoadjuvant therapy: Targeting the autophagy pathway in malignant precursor cells.
Virginia Espina(George Mason University), Kirsten H. Edmiston(Inova Health System), Rosa I. Gallagher(George Mason University), Jasbir Johal(Inova Health System), Lucio Pastore(Ceinge Biotecnologie Avanzate (Italy)), Brian D. Mariani(Genetics and IVF Institute), L A Liotta, Joy Wiedemann(Inova Health System), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), S. Banks(Inova Health System)
Cited by 0
Related Papers
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
|Cancer Cell|2022|335
Proteomic Patterns of Nipple Aspirate Fluids Obtained by SELDI‐TOF: Potential for New Biomarkers to Aid in the Diagnosis of Breast Cancer
|Disease Markers|2001|287
A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process
|Molecular & Cellular Proteomics|2008|205
Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer
|Cancer Research|2022|160